Helsinn Investment Fund: Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology

    NEXT STORY
    Trident Brands, Brain Armor and NorthShore University HealthSystem Provide Update on Brain Health Research Collaboration
    PREV STORY
    Progressive Care Inc. Subsidiary PharmCo, LLC Earns Top Performance Scores From Humana Inc.
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Valneva Reports Successful Outcome of Phase 2 Run-In for its Lyme Disease Vaccine Candidate

    author_avatar
    NASDAQ Market News

    Salarius Pharmaceuticals to Attend the Oppenheimer Healthcare Conference

    author_avatar
    NASDAQ Market News

    Immune Design to Report Second Quarter 2016 Financial Results

    SEATTLE and SOUTH SAN FRANCISCO, Calif., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Immune Design ...

    author_avatar
    NASDAQ Market News